Future studies assessing other autophagy biomarkers such as LC3B, LC3A, beclin-1, ULK1, and VPS34 will enable further understanding as to whether survival and quality of life in ALS is associated with changes in autophagosomal formation and/or autophagy flux (17). Here, MAP1LC3A is linked to amyotrophic lateral sclerosis.